Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple sclerosis in children].

R F Neuteboom1, C E Catsman-Berrevoets, R Q Hintzen

  • 1Erasmus MC, afd. Neurologie, MS-centrum ErasMS, s-Gravendijkwal 230, 3015 CE Rotterdam.

Nederlands Tijdschrift Voor Geneeskunde
|July 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Participation 1.5 years after mild traumatic brain injury in children and adolescents.

Developmental neurorehabilitation·2024
Same author

Testing for MOG-IgG in CSF: Relevant or not?

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2024
Same author

Correction: Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment.

Neurology and therapy·2024
Same author

Quality of life in children suffering from headaches: a systematic literature review.

The journal of headache and pain·2023
Same author

Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment.

Neurology and therapy·2023
Same author

Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes.

Molecular genetics and metabolism reports·2022

Pediatric multiple sclerosis (MS) diagnosis can present differently in children. Early treatment with methylprednisolone, followed by immunoglobulins or beta-interferon, effectively controlled MS in two 7-year-olds.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Pediatric MS (PMS) is rare, accounting for a small percentage of all MS cases.
  • Clinical presentation of PMS can be heterogeneous, differing from adult MS.

Observation:

  • Two 7-year-old children were diagnosed with MS.
  • The initial clinical manifestations varied significantly between the two patients.
  • One child presented with acute disseminated encephalomyelitis (ADEM).
  • The second child presented with left-sided hemiparesis.

Findings:

  • Both cases of pediatric MS were successfully managed with pharmacotherapy.
  • Treatment commenced with methylprednisolone in both patients.

Related Experiment Videos

  • The first patient received subsequent treatment with intravenous immunoglobulins.
  • The second patient was treated with beta-interferon.

    • Implications:

    • This case series highlights the diverse initial presentations of MS in children.
    • Prompt diagnosis and tailored pharmacotherapy are crucial for managing pediatric MS.
    • The findings support the efficacy of immunomodulatory treatments in pediatric MS management.
    • Further research into long-term outcomes of PMS treated with these therapies is warranted.